Sarepta Therapeutics to Announce First Quarter 2022 Financial Results and Recent Corporate Developments on May 4, 2022

Rhea-AI Summary

Sarepta Therapeutics (NASDAQ:SRPT) will announce its first quarter 2022 financial results on May 4, 2022, after market close. A conference call is scheduled for 4:30 p.m. E.T. to discuss the results and provide a corporate update. The call can be accessed by dialing (800) 895-3361 for domestic callers or (785) 424-1062 for international participants, using the passcode SAREPTA. The call will also be available via webcast on their investor relations website.

Positive

• Upcoming first quarter 2022 financial results expected to provide insight into business performance.

Negative

• None.

CAMBRIDGE, Mass., April 27, 2022 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will report first quarter 2022 financial results after the Nasdaq Global Market closes on Wednesday, May 4, 2022. Subsequently, at 4:30 p.m. E.T., the Company will host a conference call to discuss its first quarter 2022 financial results and to provide a corporate update.

The conference call may be accessed by dialing (800) 895-3361 for domestic callers and (785) 424-1062 for international callers. The passcode for the call is SAREPTA. Please specify to the operator that you would like to join the "Sarepta Therapeutics First Quarter 2022 Earnings Call." The conference call will be webcast live under the investor relations section of Sarepta.com and will be archived there following the call for 90 days. Please connect to Sarepta's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

About Sarepta Therapeutics
Sarepta is on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing. For more information, please visit www.sarepta.com or follow us on Twitter, LinkedIn, Instagram and Facebook.

Internet Posting of Information
We routinely post information that may be important to investors in the 'For Investors' section of our website at www.sarepta.com. We encourage investors and potential investors to consult our website regularly for important information about us.

Source: Sarepta Therapeutics, Inc.

Investor Contact:
Ian Estepan, 617-274-4052
iestepan@sarepta.com

Media Contact:
Tracy Sorrentino, 617-301-8566
tsorrentino@sarepta.com

FAQ

When will Sarepta Therapeutics report its first quarter 2022 financial results?

Sarepta Therapeutics will report its first quarter 2022 financial results on May 4, 2022, after market close.

What time is the Sarepta Therapeutics conference call?

The conference call will be held at 4:30 p.m. E.T. on May 4, 2022.

How can I access the Sarepta Therapeutics earnings call?

The earnings call can be accessed by calling (800) 895-3361 for domestic and (785) 424-1062 for international callers, with the passcode SAREPTA.

Will the Sarepta Therapeutics conference call be available online?

Yes, the conference call will be webcast live and available for 90 days on the Sarepta investor relations website.

What is Sarepta Therapeutics focused on?

Sarepta Therapeutics focuses on precision genetic medicine for rare diseases, particularly Duchenne muscular dystrophy and limb-girdle muscular dystrophies.